| 08:30 | P935 | Betablockers still improve survival in patients paced for bradycardia. | D H J Elder (Perth, GB) |
|
|
Abstract
|
|
|
| 08:30 | P936 | Is it safe to perform external cardioversion in patients with implanted pacemaker? | M Konert (Leipzig, DE) |
|
|
|
Abstract
|
|
|
| 08:30 | P937 | What we program is not what we get: Importance of measuring the P-wave sensing offset in DDD pacemakers. | E Aversa (Capital Federal, AR) |
|
|
|
Abstract
|
|
|
| 08:30 | P938 | Advanced AV block is associated with pulmonary hypertension which is reversible after cardiac pacing | R M Pop (Satu Mare, RO) |
|
|
|
Abstract
|
|
|
| 08:30 | P939 | Effects of the minimum ventricular stimulation associated with right ventricular outflow tract stimulation in arrhythmia, hemodynamics and quality of life of patients. | A Menezes Junior (Goiania, BR) |
|
|
|
Abstract
|
|
|
| 08:30 | P940 | Safety and efficacy of permanent pacemaker and implantable cardioverter defibrillator therapy in the nonagenarians and centenarians | A Shah (Elmhurst, US) |
|
|
|
Abstract
|
|
|
| 08:30 | P941 | Transvenous lead extraction in adolescent patients in view of lifelong pacing | R De Lucia (Pisa, IT) |
|
|
|
Abstract
|
|
|
| 08:30 | P942 | Percutaneous extraction of over one thousand permanently implanted leads in 674 pts. using mechanical systems - effectiveness and complications | A Kutarski (Jastkow Marysin, PL) |
|
|
|
Abstract
|
|
|
| 08:30 | P943 | Evaluation of clinical performance of the 4-site right ventricular defibrillation lead/header system | M Meine (Utrecht, NL) |
|
|
|
Abstract
|
|
|
| 08:30 | P944 | Cardiac device endocarditis with infected vegetations: a single-center experience and consequences of transvenous extraction | M Nagashima (Fukuoka, JP) |
|
|
|
Abstract
|
|
|
| 08:30 | P945 | The current of injury as a predictor of ventricular lead long-term stability | R Martin Asenjo (Madrid, ES) |
|
|
|
Abstract
|
|
|
| 08:30 | P946 | Systemic excess of coagulation systems after implanting device leads for low voltage devices as well as high voltage devices | T Yaegashi (Kanazawa, JP) |
|
|
|
Abstract
|
|
|
| 08:30 | P947 | Extracted leads' breakage - occurrence, management and risk factors. Analysis among over one thousand extracted leads | A Kutarski (Jastkow Marysin, PL) |
|
|
|
Abstract
|
|
|
| 08:30 | P948 | Polish registry pacemaker and icd endocardial leads extraction - How current practice reflects hrs lead consensus document | M Chudzik (Lodz, PL) |
|
|
|
Abstract
|
|
|
| 08:30 | P949 | Defibrillator implantation without fluoroscopy. | S Castrejon Castrejon (Madrid, ES) |
|
|
|
Abstract
|
|
|
| 08:30 | P950 | Incidence and predictors of antibradycardia pacing in patients with Anderson-Fabry disease. | C O'Mahony (London, GB) |
|
|
|
Abstract
|
|
|
| 08:30 | P951 | High grade atrio-ventricular block after transcatheter aortic valve implantation: permanent pacemaker is always necessary? | S Conti (S. Agata Li Battiati, IT) |
|
|
|
Abstract
|
|
|
| 08:30 | P952 | Incidence of permanent pacemaker implantation in patients undergoing transcatheter aortic valve implantation with the Medtronic CoreValve and Edwards-Sapien prosthesis. | A Radinovic (Milan, IT) |
|
|
|
Abstract
|
|
|
| 08:30 | P953 | Incidence and predictors of pericardial effusion after permanent heart rhythm device placement: | M-A G Ohlow (Bad Berka, DE) |
|
|
|
Abstract
|
|
|
| 08:30 | P954 | Is quality of life affected by pacemaker patients' incorrect perceptions? | LA Batista Sa (Goiania, BR) |
|
|
|
Abstract
|
|
|
| 08:30 | P955 | Increase of ventricular pacing demand in patients with suspected and documented atrio-ventricular blocks implanted with dual-chamber pacemaker | T Deering (Atlanta, US) |
|
|
|
Abstract
|
|
|
| 08:30 | P956 | Symptoms recurrence in dual-chamber pacemaker patients with AV conduction disorders and treated with minimized ventricular pacing. | HTJF Striekwold (Mol, BE) |
|
|
|
Abstract
|
|
|
| 08:30 | P957 | Remote monitoring requires time - invest to save? | I A Fazal (Newcastle Upon Tyne, GB) |
|
|
|
Abstract
|
|
|
| 08:30 | P958 | Para-Hisian pacing achieved with a defibrillating lead: clinical impact on LVEF | J E Val-Mejias (Wichita, US) |
|
|
|
Abstract
|
|
|
| 08:30 | P959 | Real life experience of remote monitoring - factors influencing recruitment | I A Fazal (Newcastle Upon Tyne, GB) |
|
|
|
Abstract
|
|
|
| 08:30 | P960 | Influence of cardiac dyssynchrony on physical capacity and quality of life in patients with isolated congenital heart block and chronic right ventricular pacing | R Costa (Sao Paulo, BR) |
|
|
|
Abstract
|
|
|
| 08:30 | P961 | Efficacy of high right ventricular septal lead placement for prevention of persistent atrial fibrillation | T Misawa (Kahoku-Chyo, JP) |
|
|
|
Abstract
|
|
|
| 08:30 | P962 | SafeR pacing mode consistently prevents ventricular pacing over a 2-year follow-up. | B Thibault (Montreal, CA) |
|
|
|
Abstract
|
|
|
| 08:30 | P963 | Implantation of permanent pacing leads by transcutaneous puncture of axillary vein in children and young adults with congenital heart defects (CHD): initial experience | M S Silvetti (Roma, IT) |
|
|
|
Abstract
|
|
|
| 08:30 | P964 | Mechanical dyssynchrony in non-compaction cardiomyopathy: underlying mechanism for improved response to CRT, even with narrow QRS | D Penela (Barcelona, ES) |
|
|
|
Abstract
|
|
|
| 08:30 | P965 | Severe mitral regurgitation significantly impairs SonR1 amplitude augmentation during exercise | O Baumann (Southampton, GB) |
|
|
|
Abstract
|
|
|
| 08:30 | P966 | Effect of ventricular pacing on left ventricular synchronization - validation of a novel rat model | M Mor (Beer-Sheva, IL) |
|
|
|
Abstract
|
|
|
| 08:30 | P967 | Coronary sinus ostium anatomy according different systolic function | R Mlynarski (Myslowice, PL) |
|
|
|
Abstract
|
|
|
| 08:30 | P968 | Effects of left ventricular pacing sites and av intervals on left ventricular function during acute myocardial ischemia | AM Sinha (Hof, DE) |
|
|
|
Abstract
|
|
|
| 08:30 | P969 | Cardiac resynchronisation therapy using the radpad radiation shield at implant significantly reduces radiation dose to the operator | M Jones (Oxford, GB) |
|
|
|
Abstract
|
|
|
| 08:30 | P970 | VAT-assisted lead placement: an effective method of pacing the left ventricle for cardiac resynchronisation therapy | K E Nelson (Middlesbrough, GB) |
|
|
|
Abstract
|
|
|
| 08:30 | P971 | Does selective LV lead placement via mini-thoracotomy offer an advantage over standard transvenous lead positioning in CRT device implantation? | V Velagic (Zageb, HR) |
|
|
|
Abstract
|
|
|
| 08:30 | P972 | Gender difference in placement of left ventricular lead | H Kawata (San Diego, US) |
|
|
|
Abstract
|
|
|
| 08:30 | P973 | Cardiac resynchronization therapy and atrial fibrillation: three leads better than two | I Fernandez Lozano (Madrid, ES) |
|
|
|
Abstract
|
|
|
| 08:30 | P974 | Anatomical factors involved in difficult cardiac resynchronization therapy procedure | A Gate-Martinet (Saint-Etienne, FR) |
|
|
|
Abstract
|
|
|
| 08:30 | P975 | A new non-invasive method to assess systolic and diastolic interval changes in patients treated by resynchronization therapy: a feasibility study | U Startari (Pisa, IT) |
|
|
|
Abstract
|
|
|
| 08:30 | P976 | LV ring cathodal stimulation causes less diaphragmatic pacing than LV tip cathodal stimulation | S Adhya (London, GB) |
|
|
|
Abstract
|
|
|
| 08:30 | P977 | Early improvements in heart rate variability after cardiac resynchronization therapy | D Klug (Lille, FR) |
|
|
|
Abstract
|
|
|
| 08:30 | P978 | Left ventricular Tei index: value in predicting response to cardiac resynchronization therapy | N Cortez-Dias (Lisbon, PT) |
|
|
|
Abstract
|
|
|
| 08:30 | P979 | A novel analysis program using 64-multidetector row computed tomography for the evaluation of left ventricular mechanical dyssynchrony | T Keida (Tokyo, JP) |
|
|
|
Abstract
|
|
|
| 08:30 | P980 | Will the benefits of cardiac resynchronization therapy be extended to patients with atrial fibrillation? | A Meireles (Porto, PT) |
|
|
|
Abstract
|
|
|
| 08:30 | P981 | Permanent para-hisian pacing. Indications and follow-up | D F Ortega (San Fernando, AR) |
|
|
|
Abstract
|
|
|
| 08:30 | P982 | Baseline Nt-proBNP and peak VO2 are not predictive of positive response to cardiac resynchronization therapy in patients with chronic heart failure. | T Chwyczko (Warsaw, PL) |
|
|
|
Abstract
|
|
|
| 08:30 | P983 | What is the clinical predictors of left ventricular reverse remodeling after cardiac resynchronization therapy in pacemaker-dependent patients with heart failure? | I Nakajima (Osaka, JP) |
|
|
|
Abstract
|
|
|
| 08:30 | P984 | Longitudinal axis of left ventricle in heart failure, role of diminished septum shrinkage in mitral regurgitation formation | A Kutarski (Jastkow Marysin, PL) |
|
|
|
Abstract
|
|
|
| 08:30 | P985 | Cost-effectiveness of cardiac resynchronization therapy in patients with heart failure: the perspective of a middle-income country's public health system | I Zimerman (Porto Alegre, BR) |
|
|
|
Abstract
|
|
|
| 08:30 | P986 | Profiles of ventricular rate during atrial fibrillation in CRT recipients | G Boriani (Bologna, IT) |
|
|
|
Abstract
|
|
|
| 08:30 | P987 | Is benefit of temporary cardiac resynchronization therapy during cardiac surgery sustained after chest closure? A substudy of the Biventricular Pacing After Cardiac Surgery (BiPACS) trial. | B J Rubinstein (New York, US) |
|
|
|
Abstract
|
|
|
| 08:30 | P988 | A randomized comparison of mechanical dyssynchrony and hemodynamic response in right ventricular apical versus high posterior septal pacing in cardiac resynchronization therapy | H M Kristiansen (Bergen, NO) |
|
|
|
Abstract
|
|
|
| 08:30 | P989 | Gender difference in the prognosis of patients with cardiac resynchronization therapy | H Kawata (San Diego, US) |
|
|
|
Abstract
|
|
|
| 08:30 | P990 | Optimization of v-v delay interval in CRT using Echocadiography compared to QRS width in surface ECG | A Nawar (6 October, EG) |
|
|
|
Abstract
|
|
|
| 08:30 | | Ten years follow up (f.u.) after cardiac resynchronization therapy (CRT): the widest the baseline QRS the highest the cardiac mortality (CM)? | |
|
| 08:30 | P991 | Traditional predictors of mortality in heart failure patients do not predict mortality in CRT patients | E Nof (Tel Hashomer, IL) |
|
|
|
Abstract
|
|
|
| 08:30 | P992 | Intermediate term follow up of left ventricular only pacing in patients candidate for cardiac resynchronization therapy | H Badran (Cairo, EG) |
|
|
|
Abstract
|
|
|
| 08:30 | P993 | Cardiac resynchronization therapy in patients with atrial fibrillation: is it really mandatory to ablate the AV junction to achieve a good response? | J M Tolosana (Barcelona, ES) |
|
|
|
Abstract
|
|
|
| 08:30 | P994 | Impact of mitral regurgitation on the outcome of heart failure patients treated with a biventricular defibrillator: 'real world data' from the InSync ICD Italian Registry | G Boriani (Bologna, IT) |
|
|
|
Abstract
|
|
|
| 08:30 | P995 | Clinical predictors of CRT response: results from the clinical evaluation on advanced resynchronization trial (CLEAR) study | M Lunati (Milano, IT) |
|
|
|
Abstract
|
|
|